These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 28028556)

  • 41. Proton density fat-fraction is an accurate biomarker of hepatic steatosis in adolescent girls and young women.
    Rehm JL; Wolfgram PM; Hernando D; Eickhoff JC; Allen DB; Reeder SB
    Eur Radiol; 2015 Oct; 25(10):2921-30. PubMed ID: 25916386
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Accuracy of Multi-echo Dixon Sequence in Quantification of Hepatic Steatosis.
    Yurdaisik I; Nurili F
    Cureus; 2020 Feb; 12(2):e7103. PubMed ID: 32231898
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improved free-breathing liver fat and iron quantification using a 2D chemical shift-encoded MRI with flip angle modulation and motion-corrected averaging.
    Starekova J; Zhao R; Colgan TJ; Johnson KM; Rehm JL; Wells SA; Reeder SB; Hernando D
    Eur Radiol; 2022 Aug; 32(8):5458-5467. PubMed ID: 35307745
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proton density fat fraction MRI of vertebral bone marrow: Accuracy, repeatability, and reproducibility among readers, field strengths, and imaging platforms.
    Schmeel FC; Vomweg T; Träber F; Gerhards A; Enkirch SJ; Faron A; Sprinkart AM; Schmeel LC; Luetkens JA; Thomas D; Kukuk GM
    J Magn Reson Imaging; 2019 Dec; 50(6):1762-1772. PubMed ID: 30980694
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optimizing signal intensity correction during evaluation of hepatic parenchymal enhancement on gadoxetate disodium-enhanced MRI: comparison of three methods.
    Onoda M; Hyodo T; Murakami T; Okada M; Uto T; Hori M; Miyati T
    Eur J Radiol; 2015 Mar; 84(3):339-345. PubMed ID: 25543887
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of Gd-EOB-DTPA on proton-density fat fraction in the liver using chemical shift-encoded magnetic resonance imaging at 3-T.
    Suzuki M; Hayashi T; Nashiki K; Kawata H; Nagata S; Abe T
    Radiol Phys Technol; 2024 Sep; 17(3):637-644. PubMed ID: 38730134
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of sequential proton density fat fraction for quantification of hepatic steatosis in nonalcoholic fatty liver disease.
    Idilman IS; Keskin O; Elhan AH; Idilman R; Karcaaltincaba M
    Scand J Gastroenterol; 2014 May; 49(5):617-24. PubMed ID: 24694249
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Segmental quantification of hepatic lipid content based on volumetric MRI data in patients with suspected iron overload.
    Wunderlich AP; Cario H; Kannengießer S; Grunau V; Götz M; Hüttner F; Backhus J; Beer M; Schmidt SA
    Rofo; 2024 May; 196(5):463-470. PubMed ID: 38081191
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis.
    Tang A; Tan J; Sun M; Hamilton G; Bydder M; Wolfson T; Gamst AC; Middleton M; Brunt EM; Loomba R; Lavine JE; Schwimmer JB; Sirlin CB
    Radiology; 2013 May; 267(2):422-31. PubMed ID: 23382291
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of optimal scan delay for gadoxetate disodium-enhanced hepatic arterial phase MRI using MR fluoroscopic triggering and slow injection technique.
    Goshima S; Kanematsu M; Kondo H; Watanabe H; Kawada H; Moriyama N; Bae KT
    AJR Am J Roentgenol; 2013 Sep; 201(3):578-82. PubMed ID: 23971449
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differences in multi-echo chemical shift encoded MRI proton density fat fraction estimation based on multifrequency fat peaks selection in non-alcoholic fatty liver disease patients.
    Martí-Aguado D; Alberich-Bayarri Á; Martín-Rodríguez JL; França M; García-Castro F; González-Cantero J; González-Cantero Á; Martí-Bonmatí L
    Clin Radiol; 2020 Nov; 75(11):880.e5-880.e12. PubMed ID: 32888653
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of Gd-EOB-DTPA on proton density fat fraction using the six-echo Dixon method in 3 Tesla magnetic resonance imaging.
    Hayashi T; Fukuzawa K; Kondo H; Onodera H; Toyotaka S; Tojo R; Yano S; Tano M; Miyati T; Kotoku J; Okamoto T; Toyoda K; Oba H
    Radiol Phys Technol; 2017 Dec; 10(4):483-488. PubMed ID: 28895045
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Optimization of region-of-interest sampling strategies for hepatic MRI proton density fat fraction quantification.
    Hong CW; Wolfson T; Sy EZ; Schlein AN; Hooker JC; Fazeli Dehkordy S; Hamilton G; Reeder SB; Loomba R; Sirlin CB
    J Magn Reson Imaging; 2018 Apr; 47(4):988-994. PubMed ID: 28842937
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cross-sectional correlation between hepatic R2* and proton density fat fraction (PDFF) in children with hepatic steatosis.
    Mamidipalli A; Hamilton G; Manning P; Hong CW; Park CC; Wolfson T; Hooker J; Heba E; Schlein A; Gamst A; Durelle J; Paiz M; Middleton MS; Schwimmer JB; Sirlin CB
    J Magn Reson Imaging; 2018 Feb; 47(2):418-424. PubMed ID: 28543915
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of proton density fat fraction (PDFF) obtained from a vendor-neutral MRI sequence and MRQuantif software.
    Orcel T; Chau HT; Turlin B; Chaigneau J; Bannier E; Otal P; Frampas E; Leguen A; Boulic A; Saint-Jalmes H; Aubé C; Boursier J; Bardou-Jacquet E; Gandon Y
    Eur Radiol; 2023 Dec; 33(12):8999-9009. PubMed ID: 37402003
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Validation of a motion-robust 2D sequential technique for quantification of hepatic proton density fat fraction during free breathing.
    Pooler BD; Hernando D; Ruby JA; Ishii H; Shimakawa A; Reeder SB
    J Magn Reson Imaging; 2018 Dec; 48(6):1578-1585. PubMed ID: 29665193
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Spatial distribution of MRI-Determined hepatic proton density fat fraction in adults with nonalcoholic fatty liver disease.
    Bonekamp S; Tang A; Mashhood A; Wolfson T; Changchien C; Middleton MS; Clark L; Gamst A; Loomba R; Sirlin CB
    J Magn Reson Imaging; 2014 Jun; 39(6):1525-32. PubMed ID: 24987758
    [TBL] [Abstract][Full Text] [Related]  

  • 58. T1 bias in chemical shift-encoded liver fat-fraction: role of the flip angle.
    Kühn JP; Jahn C; Hernando D; Siegmund W; Hadlich S; Mayerle J; Pfannmöller J; Langner S; Reeder S
    J Magn Reson Imaging; 2014 Oct; 40(4):875-83. PubMed ID: 24243439
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Feasibility of modified Dixon MRI techniques for hepatic fat quantification in hepatic disorders: validation with MRS and histology.
    Kang BK; Kim M; Song SY; Jun DW; Jang K
    Br J Radiol; 2018 Sep; 91(1089):20170378. PubMed ID: 29022777
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison between modified Dixon MRI techniques, MR spectroscopic relaxometry, and different histologic quantification methods in the assessment of hepatic steatosis.
    Kukuk GM; Hittatiya K; Sprinkart AM; Eggers H; Gieseke J; Block W; Moeller P; Willinek WA; Spengler U; Trebicka J; Fischer HP; Schild HH; Träber F
    Eur Radiol; 2015 Oct; 25(10):2869-79. PubMed ID: 25903702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.